To explore the possible mechanisms underlying the effects of ST6Gal-I on the malignant behaviors of HCC cells, we analyzed the PI3K/Akt, MAPK and Wnt/β-catenin signaling pathways. The gene discussed is ST6GAL1; the disease is hepatocellular carcinoma.